| |
disability
| Date |
Type |
Title |
|
Jul 01, 2008 |
Article,ClinicalTrial,DrugNews,Events |
UCLA – Trial of drug to improve cognition & function in adults with depression, ages 60 and older (not yet recruiting)
This 16-week NIH-sponsored study in Los Angeles – Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults with Depression - will recruit patients age 60 and older. |
|
May 02, 2008 |
Abstract |
Treatment of osteoarthritis with PycnogenolR. The SVOS (San Valentino Osteo-arthrosis Study): Evaluation of signs, symptoms, physical performance and vascular aspects – Source: Phytotherapy Research, Apr 2008
Osteoarthritis study reports supplementation with antioxidant bark extract may support symptom improvement & analgesic use reduction.[Source: Phytotherapy Research, Apr 2008] |
|
Mar 18, 2008 |
Abstract |
Evidence for Acquired Pregenual Anterior Cingulate Gray Matter Loss from a Twin Study of Combat-related Posttraumatic Stress Disorder - Source: Biological Psychiatry, March 15, 2008
Findings from this multi-center study “suggest that volume reductions in [the brain’s anterior cingulate cortex] associated with PTSD arise as a consequence of stress exposure rather than emerging as a heritable trait.” Full text of the report is available free online. [Source: Biological Psychiatry, March 15, 2008] |
|
Mar 10, 2008 |
Chat |
Letters From Our Readers - Comments & Suggestions 03-12-08
Letters From Our Readers - Comments & Suggestions 03-12-08 |
|
Feb 12, 2008 |
Chat |
Letters From Our Readers - Q&A Session 02-13-08
Letters From Our Readers - Q&A Session 02-13-08 |
|
Mar 29, 2006 |
Abstract |
Abstract: Lower Plasma Vitamin E Levels Are Associated With the Frailty Syndrome: The InCHIANTI Study
We tested the hypothesis that, independent of confounders, low plasma levels of vitamin E (alpha-tocopherol), the main fat-soluble human antioxidant, are associated with the frailty syndrome in older persons free from dementia and disability. |
|
Mar 08, 2006 |
Article |
Excerpt from "Healing Pain: The Innovative, Breakthrough Plan to Overcome Your Physical Pain & Emotional Suffering"
According to authors Ann Berger, M.S.N, M.D., and C.B. deSwaan, "It's clear that pain is understood by anyone and that everyone feels it a bit differently. Overall, pain is an unpleasant sensation that occurs in varying degrees of severity and is a consequence of a number of processes. In order to manage pain, doctors discern its intensity and frequency and the circumstance from which it springs." |
|
Jan 05, 2006 |
Article |
Fox Foundation Grant Funds Major Gene Therapy Advance for Treatment of Parkinson's Disease
An innovative gene therapy approach pioneered by Pennsylvania-based RheoGene Inc. will be further refined and tested in preliminary clinical trials within four years, thanks to a $4.2 million grant from the Michael J. Fox Foundation for Parkinson's Research (MJFF). |
|
Nov 21, 2005 |
Article |
Study of Glucosamine and Chondroitin Demonstrates Benefit for Osteoarthritis Patients
The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) sponsored by the NIH adds to a growing body of scientific evidence showing that the two supplements can safely alleviate pain from osteoarthritis, a chronic condition known as the "wear-and-tear" kind of arthritis that afflicts 21 million Americans each year. |
|
Sep 21, 2005 |
Article |
UQ Researcher Tracking Key to Healing the Brain
Stem cells have long been described as the holy grail of bioscientists. These amazing cells have the remarkable potential to develop into many different cell types in the body and have to potential to revolutionise medical science. |
|
|
Next 10 Articles>> |
|
|
|
|
